Skip to main content
Premium Trial:

Request an Annual Quote

DNA Dilemma

A reader writes in to The New York Times Magazine to ask about the ethics of DNA testing — the reader doesn't want to be tested, citing privacy concerns, but the reader's siblings want to learn about their genealogy through DNA testing. Ariel Kaminer, the Times' ethics columnist, recommends first considering whether "genetic testing [is] even worthwhile." She cites a report from the US Government Accountability Office that found many direct-to-consumer genetic tests have "inaccurate results and [make] exaggerated claims." As for privacy concerns, Kaminer notes that companies can't sell or use customers' data without permission, "but the fine print on those consent forms goes by so quickly that it can be hard to follow." In the end, Kaminer recommends educating the siblings about the limitations of testing and the significance of the consent forms. "Your siblings should consider how their actions affect you, but ultimately their genes are their own, however strong the family resemblance," she says.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.